MARRONE BIO INNOVATIONS’ REGALIA® MAXX BIOFUNGICIDE RECEIVES REGISTRATION IN BRAZIL

First Approved Plant Extract-Based Fungicide in Brazil Brings Growers New Solution for Protecting Against Disease, Resulting in Higher Quality and Yields

December 17, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA® MAXX Biofungicide has received a product registration from Brazil’s Ministry of Agriculture (MAPA). Brazil now joins Peru, El Salvador, Guatemala, Honduras, Panama, Columbia, the Dominican Republic and Mexico as Latin American countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.

REGALIA MAXX is the first plant extract-based fungicide approved in Brazil and is the first biopesticide with Induced Systemic Resistance (ISR), a complex mode of action which creates a defense response in the treated plants and stimulates additional biochemical pathways that strengthen the plant structure and act against the pathogen. The newly approved uses for REGALIA MAXX in Brazil, include tomatoes, potatoes, and dried beans.  MBI is working with its partner FMC to expand the label to include a broader array of crops and diseases, such as citrus and row crops.

“REGALIA MAXX brings Brazilian growers an environmentally responsible and effective solution for protecting against a variety of fungal and bacterial diseases, resulting in higher quality and improved yields,” said MBI, CEO Pam Marrone.  “This registration is critical to our global expansion plan for MBI products and we believe it will fill a real need for growers in Brazil. REGALIA MAXX can be used as a standalone product or in combination with other fungicides to strengthen integrated pest management programs, improve plant health and boost yields.”

REGALIA MAXX is an advanced biofungicide that can minimize chemical residues by being used alone in a disease-control program, particularly for exported crops at the end of the season right before harvest or in rotation with synthetic fungicides or in a tank mix. The product induces a plant’s natural defenses to protect against a variety of fungal and bacterial diseases and features multiple modes of action, which helps to prevent or delay the development of disease resistance. It also provides a four-hour re-entry interval that increases operational flexibility and a zero-day post-harvest interval so crop quality can be protected right up to harvest. REGALIA MAXX is proven to control diseases such as powdery mildews on cucurbits (melons, cucumber, zucchini), cane berries, tomatoes (including tomatillo), eggplant, peppers, grapes and ornamentals; Alternaria on tomatoes and potatoes; anthracnose on avocado, mango, papaya and citrus.

*******

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding: the anticipated filing date of the Company’s Form 10-Q and the Company’s expectations regarding regaining full compliance with NASDAQ continued listing requirements. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include the uncertainty surrounding the timing and results of the Audit Committee’s independent investigation of accounting matters, the potential need for restatement of our prior period financial statements, how promptly the investigation of accounting matters can be completed and any results thereof can be resolved, and potential legal or regulatory action related to the matters under investigation. In addition, the Company faces other risks and uncertainties that could affect its ability to complete the filing of its Form 10-Q and to regain compliance with the NASDAQ listing requirements. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Guest Opinion: Biologicals Play Key Role in Food Production

THE GROWER, Vance Publishing Corporation
Written by Dr. Pamela Marrone, founder and chief executive officer of Marrone Bio Innovations, Davis, Calif.
12/04/2014

EDITOR’S NOTE: This is a guest column and opinions expressed here are only those of the author and do not necessarily reflect those of Vance Publishing Corporation.

Now more than ever, fruit and vegetable growers need effective and environmentally sustainable pest management programs to protect against crop diseases, improve food yields and quality, and feed a growing and increasingly food-conscious world.

Biopesticides or “biologicals” are becoming an important tool in the grower’s toolbox by promoting plant health and controlling unwanted pests and diseases, leading to better yields with reduced environmental impact – as well as an improved bottom line for growers.

What are ‘biologicals’?

Made from naturally occurring substances, such as microorganisms, plant extracts, fatty acids or pheromones, biologicals can also play a role in helping growers address consumer issues such as worker safety, toxicity to wildlife, air pollution, and surface and groundwater contamination. Biopesticides break down quickly and efficiently in the environment, leaving little chemical traces.

Although they can be effective as a standalone treatment, most biopesticides are used in conjunction with traditional chemicals as part of an integrated pest management program. Here, their efficacy and quality are enhanced compared with chemical-only programs, especially for crops like fruits, vegetables, nuts and ornamentals.

Biopesticides are considered among the best low-risk and most effective tools for achieving crop protection in IPM systems. Research, field trials, and performance history prove that the most effective IPM programs typically consist of biopesticides used in combination tank-mixes or in rotation with conventional chemical products.

Typically, biopesticide field trials conducted by consultants or university researchers compare a biological standalone to the best chemical treatments, which may include tank-mixes. If the standalone biological is not as effective as the chemical(s), often the work stops there and the results reported, “The biological did not work as well as the chemical(s).”

Take an integrated approach

Therefore it is critical to integrate the biological into the program and not just assess them standalone. Very often the integrated program results in marketable yields and quality that can exceed chemical-only programs.

Even if the results are the same as the chemical-only program, the program is enhanced with the ability to manage residues, delay resistance, increase labor flexibility and enhance beneficials.

The key to maximizing the performance of biopesticides and IPM programs is to understand the modes of action of the biological compared to the chemical. Best use is understanding how they work, rather than asking, “Do they work?”

Many biopesticides are slower acting than chemicals and can take several days to see pest mortality. Some stop feeding, reduce reproduction and inhibit molting.

Counting just pest mortality rather than measuring crop damage, yields or season long population suppression, may mask the overall benefits to the program. Biofungicide use in an integrated program can often result in increased marketable yields while overall percent disease control is less than the chemicals in standalone trials.

Take a program approach

When used in IPM programs, biopesticides offer additional benefits, such as complex and novel modes of action for resistance management to extend the product life of conventional pesticides. Biologicals provide flexibility to traditional farming operations with reduced pre-harvest intervals to manage residues for exported produce, as well as shorter field reentry times for workers—ultimately reducing labor costs.

Biopesticides can also provide high margins of safety for applicators, farm workers and rural neighbors and typically have shorter field restricted-entry intervals, which makes it easier for farmers to complete essential agronomic practices on a timely basis and schedule harvests.

Biopesticides notably target specific pests without disrupting the beneficial components of the surrounding ecosystem. Although many insect species have a negative effect on crop production, some species, such as honeybees, predators and parasitoids, can have a positive effect.

These benefits may derive from the insect’s role as a pollinator or by acting as a natural predator to the insects causing damage.

Pest resistance to conventional chemical pesticides is another significant concern to the agricultural industry. As new classes of reduced-risk chemistries continue to be introduced to commercial growers, the challenge of resistance management must be met with thoughtful use of diverse, season-long pest control programs.

Whether used alone or in combination with conventional pesticides, biopesticides offer an important tool for enabling grower’s to effectively promote plant health, control unwanted pests and feed a growing population with reduced environmental impacts – while also improving profitability.

MARRONE BIO INNOVATIONS ANNOUNCES NEW CORPORATE HEADQUARTERS LOCATION

December 2, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has relocated its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, effective December 8, 2014.

The new office and laboratory spaces are approximately 45,000 square feet and will house all of the Company’s corporate functions as well as research and development.  The laboratory space is designed to create a collaborative and productive work environment and to enhance safety.  With expanded facilities in fermentation, formulation, and greenhouses, this new space is intended to support MBI’s commitment to discovering and developing effective and environmentally responsible bio-based products that promote plant health and control unwanted pests in agriculture and water treatment markets.

The Company’s business numbers remain the same: Tel: 1.530.750.2800 / Fax: 1.530.750.2808

*******

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding: the anticipated filing date of the Company’s Form 10-Q and the Company’s expectations regarding regaining full compliance with NASDAQ continued listing requirements. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include the uncertainty surrounding the timing and results of the Audit Committee’s independent investigation of accounting matters, the potential need for restatement of our prior period financial statements, how promptly the investigation of accounting matters can be completed and any results thereof can be resolved, and potential legal or regulatory action related to the matters under investigation. In addition, the Company faces other risks and uncertainties that could affect its ability to complete the filing of its Form 10-Q and to regain compliance with the NASDAQ listing requirements. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Marrone Bio Innovations’ Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture

November 13, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 “Green Agribusiness Award” from the Michigan Agri-Business Association (MABA).

The awards recognize companies for pursuing sustainability requirements across the scope of agricultural production that help agriculture further protect water quality and the Great Lakes, and achieve the greatest possible yields while protecting the environment.

“Every day, consumers are more connected to our food system and they want to know that Michigan agriculture is producing food in a sustainable way,” said Jim Byrum, President of MABA.  “In addition, our industry knows the value of protecting our air, water and Great Lakes for coming generations. By pursuing a wide range of sustainability criteria under the Green Agribusiness Designation Program, companies across the state, such as Marrone Bio Innovations, are leading the way on this important issue.”

The M3 facility, which held its Grand Opening on July 1, 2014, is a wholly-owned subsidiary of MBI. Currently three MBI product lines are being produced at the M3 facility: REGALIA® and REGALIA Rx®, which are biofungicides, GRANDEVO®, which is a bioinsecticide and ZEQUANOX®, which is a biomolluscicide to control invasive zebra and quagga mussels.

“On behalf of the entire MBI team, I would like to thank the Michigan Agri-Business Association for recognizing our contributions to sustainable agriculture,” said Gordon Grove, MBI’s M3 Plant Manager.  “Southwest Michigan is positioned at the forefront of a growing global movement to firmly establish biologically based technologies as the foundation in agriculture, turf, ornamental and water treatment markets. As the world looks for answers to sustainably feed 9 billion people, M3 and Southwest Michigan will be providing safe, smart and effective solutions to big challenges confronting humanity and the environment.”

*******

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

As previously disclosed in the Company’s Form 8-K dated September 3, 2014, the Company’s Audit Committee has commenced an internal investigation. The Audit Committee has not yet concluded its investigation and the Company does not expect it will be in a position to discuss financial results until after the investigation is completed.

The uncertainty surrounding the timing and results of the Audit Committee investigation could impact the timing of Company’s discussion of its financial results. Additional relevant information concerning developments in the Audit Committee investigation may be found in the Company’s filings with the Securities and Exchange Commission from time to time.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Marrone Bio Innovations CEO Pam Marrone Receives Agrow Award for Best Manager With a Strategic Vision

DAVIS, Calif., Oct. 30, 2014 — Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that its Founder and Chief Executive Officer Pam Marrone has received a 2014 Agrow Award for “Best Manager with Strategic Vision.” Marrone was honored at the Agrow Awards’ 2014 ceremony and dinner last night in Amsterdam.

The inaugural “Best Manager with Strategic Vision” award recognizes a manager who through a strategic initiative was able to achieve clearly identifiable targets in areas such as new product launches, new market penetration and company performance.

“I am extremely honored to have received this prestigious award,” said Pam Marrone, CEO of MBI. “Our strategic vision is focused on discovering and developing effective and environmentally responsible bio-based products that promote plant health and control unwanted pests in agriculture. We look forward to continuing to execute on this vision and bringing new agricultural innovations to market through Integrated Pest Management. On behalf of my colleagues at MBI who are critical to making our vision a reality, I would like to thank the Agrow Awards for honoring our company with this award.”

MBI was also a 2014 Agrow Award finalist for “Best Industry Collaboration” for its partnership with DSM Food Specialties B.V. (DSM), a Netherlands-based manufacturer of specialty ingredients for international food and beverage industries. MBI’s strategic partnership with DSM is focused on maximizing the potential power, reach and value of novel active ingredients for bio-based products that promote plant health and control unwanted pests in agriculture. Through this collaboration, both companies and their respective industries at either end of the food supply chain stand to benefit from the identification of new bio-based solutions for improved crop production and food safety.

The prestigious Agrow Awards, presented by Agrow, a leading information provider for the global crop protection industry, features 13 categories in areas such as R&D, formulation, innovation, collaboration, marketing, business strategy and corporate responsibility. Candidates were judged by an independent panel of industry experts, before announcing the winners on October 29th.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Brian Ahrens Joins Marrone Bio Innovations as Vice President of Sales

October 27, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the Brian Ahrens smallagriculture, turf and ornamental and water treatment markets, today announced that Brian Ahrens has joined the company as its Vice President of Sales.   In this role, Ahrens will be responsible for driving U.S. and international sales of MBI’s portfolio of products to growers through distributors and retailers of agriculture products.

Pam Marrone, Chief Executive Officer of Marrone Bio Innovations, said, “There are significant domestic and international growth opportunities for our bio-based agricultural solutions as more growers and companies put an emphasis on environmental sustainability and improved agricultural productivity.  Brian strengthens our management team and sales organization as we add depth and build out our sales team in order to capitalize on these opportunities.  Brian will play a critical role in driving sales and expanding our market reach for our bio-based products, which promote plant health and control unwanted pests in agriculture and water.”

A veteran of the agriculture industry with 20 years of business and industry experience, Ahrens joins MBI from ADAMA Agriculture Solutions (formerly Mahkteshium Agan – MANA) where he served as Strategic Business Leader, Innovation Leader, Northern Regional Business Manager and Senior Product Manager. Prior to his time at ADAMA, Ahrens held multiple positions with BASF Corporation, Bayer CropScience, Aventis CropScience and Rhône-Poulenc Ag Company.  Ahrens has a B.S. in Agricultural Business from Iowa State University, with a concentration in marketing and sales.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

As previously disclosed in the Company’s Form 8-K dated September 3, 2014, the Company’s Audit Committee has commenced an internal investigation. The Audit Committee has not yet concluded its investigation and the Company does not expect it will be in a position to discuss financial results until after the investigation is completed.

The uncertainty surrounding the timing and results of the Audit Committee investigation could impact the timing of Company’s discussion of its financial results. Additional relevant information concerning developments in the Audit Committee investigation may be found in the Company’s filings with the Securities and Exchange Commission from time to time.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Zequanox® Achieves 100% Mortality for Invasive Mussels in Minnesota Lake

Biological product used at Christmas Lake near Minneapolis kills zebra mussels

Treatment Area - 11 DAT (800x600)

Christmas Lake treatment area in Shoreview, Minnesota, 11 days following Zequanox treatment, which resulted in 100 percent mortality of the invasive mussels.

DAVIS, Calif., September 30, 2014 – Marrone Bio Innovations, Inc. (MBI) [Nasdaq: MBII], a leading global provider of bio-based pest management and plant health products announced today the successful results of a Zequanox treatment conducted at Christmas Lake in Shorewood, Minn.

Minnesota Department of Natural Resources and the Minnehaha Creek Watershed District’s (MCWD) Aquatic Invasive Species (AIS) Program requested Zequanox treatment from MBI after discovering zebra mussels near the public boat launch. The non-chemical product approved for use in open water was applied to a 50 by 60 foot containment area with an average depth of 2.5 feet. Before treating, there were approximately 5,000 live mussels in the enclosure.  The treatment began on September 8 and eleven days later results showed 100 percent mortality of the zebra mussels in the treatment area.

“We are extremely pleased that Zequanox was so effective in the Christmas Lake treatment,” said Keith Pitts, Vice President of Regulatory Affairs for MBI. “The watershed district and the Minnesota DNR have been great partners, and we’re happy to continue to see proven results for invasive mussel control. It’s a comforting outcome for the public as well, because this solution is more environmentally friendly than other mussel control products and can be administered without harming people, pets or the environment.”

MCWD staff monitored the effectiveness of Zequanox by counting dead mussels over time in the treatment area using collected mussels placed in cages and by searching the area for mussels attached to rocks.  Also, they monitored aquariums in a laboratory that held treated water and mussels from Christmas Lake.

“Marrone Bio Innovations has been a key partner in the first phase of our response,” said Craig Dawson, director of MCWD’s AIS Program. “What we’ve learned from the treatment bodes well for future efforts to contain zebra mussel infestations, especially when they’re caught early like the Christmas Lake case.”

Invasive mussel populations are now prevalent in major waterways throughout the country, including the Great Lakes Region as well as the Mississippi, Arkansas, Tennessee and Colorado rivers. The mussels have a significant economic and environmental impact on recreational water use. Colonies of invasive zebra and quagga mussels negatively impact native mussel populations, disrupt the natural ecosystem and cause proliferation of toxic blue-green algae. They decrease game fish populations, which can have a serious effect on the economic health of the fishing industry. Swimmers run the risk of injury from the invasive mussels’ sharp shells, and water intakes from infested lakes and rivers used for irrigation, fire suppression and drinking water can suffer impeded or blocked flow and damage to infrastructure and equipment.

Zequanox is the industry’s only selective and environmentally compatible molluscicide, which was first approved by the EPA in 2012 for mussel control in enclosed systems and infrastructures for energy producers, manufacturing companies and golf courses. The EPA approved Zequanox in July for open water use and as a result, the product is now available to private waterfront owners and natural resource managers as an effective solution to control existing populations of invasive mussels or knock back new infestations without the use of environmentally harmful treatments, such as potash and copper-based products.

Composed of dead cells derived from a naturally occurring soil microbe, Zequanox controls mussels in all life stages. Unlike toxic treatments, such as potash and copper-based solutions, Zequanox is biodegradable and noncorrosive. In addition, Zequanox is highly selective to control only the invasive zebra and quagga mussels, is effective in a broad range of water conditions and according to the EPA, its active ingredient has “low toxicity and presents little risk to non-target organisms.”

Zequanox is applied directly into an open body of water, such as a lake or river, using standard injection equipment. Treatments can occur during any time of the day while people and pets are present, and can be completed within hours. The product offers additional flexibility because it is proven to be effective in a broader range of water conditions.

The product offers a zero hour re-entry interval, so there is no waiting period after treatment that might interfere with commercial or recreational use of a waterway, such as fishing, swimming or boating. The U.S. EPA determined Zequanox was exempt from the requirement of a food tolerance, which indicates that there is no concern with using treated water to irrigate crops or that eating fish caught in waters treated by Zequanox poses any risk to consumers.

Traditional chemical products do exist to effectively treat invasive mussel populations, however they can leave damaging environmental impacts. Solutions containing potash (potassium chloride, KCI) and copper based products can kill endangered and threatened native mussel species.  Also, use of potash- and copper-based products lead to public heath concerns resulting in restricted drinking water use from reservoirs and prohibitions on recreational use for extended periods. Both chemicals are toxic to non-targeted organisms and persist in the environment, causing prolonged ecosystem exposure.

###

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs,  hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-Q that the Company filed with the Securities and Exchange Commission on May 15, 2014.

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 37